ClinicalTrialStartPulse: Phase 1, page 2 of 4
Records 51 to 200 of the 500 newest listed for this hub. Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2.
| Record | Phase | Conditions | Enrollment |
|---|---|---|---|
| Hunan Kelun Pharmaceutical Co., Ltd. | Phase 1 | Healthy Participants | 20 |
| Astellas Pharma Global Development, Inc. | Phase 1 | Healthy Volunteer | 8 |
| AstraZeneca | Phase 1 | Healthy | 32 |
| Arcus Biosciences, Inc. | Phase 1 | Advanced Cancer; Advanced Malignancies; Bladder Cancer; Cervical Cancer; Esophageal Cancer; Gastric Cancer | 40 |
| Jemincare | Phase 1 | ADPKD (Autosomal Dominant Polycystic Kidney Disease); Renal Edema | 32 |
| SunGlow Innovations LLC | Phase 1 | Solid Tumor; Neoplasms | 50 |
| AstraZeneca | Phase 1 | Healthy Participants | 60 |
| Amgen | Phase 1 | Obesity; Overweight | 180 |
| Medicovestor, Inc | Phase 1 | Pancreatic Ductal Adenocarcinoma (PDAC); Advanced Solid Tumor Cancer; Metastatic Pancreatic Cancer; Metastatic Solid Tumors | 40 |
| Merck Sharp & Dohme LLC | Phase 1 | Healthy | 28 |
| Sachi Bioworks Inc. | Phase 1 | Amyotrophic Lateral Sclerosis (ALS) | 40 |
| Shanghai Qilu Pharmaceutical Research and Development Center LTD | Phase 1 | Systemic Lupus Erythematosus; Rheumatoid Arthritis (RA); Primary Sjögren's Syndrome (pSS); Systemic Sclerosis (SSc) | 76 |
| Shanghai Hengrui Pharmaceutical Co., Ltd. | Phase 1 | Pancreatic Cancer | 18 |
| Immunis, Inc. | Phase 1 | Dyskinesia, Medication-induced; Dyskinesia, Drug-Induced | 15 |
| Neurelis, Inc. | Phase 1 | Cerebral Cavernous Malformation | 40 |
| Pfizer | Phase 1 | Healthy | 26 |
| Amgen | Phase 1 | Asthma | 21 |
| Shanghai YingLi Pharmaceutical Co. Ltd. | Phase 1 | Solid Tumors; Ovarian | 45 |
| Guangdong ProCapZoom Biosciences Co., Ltd. | Phase 1 | Keratitis; Autoimmunity; Dry Eye Disease (DED) | 20 |
| GlaxoSmithKline | Phase 1 | Hepatitis B | 98 |
| Guizhou Sinorda Pharmaceutical Co., Ltd. | Phase 1 | Colorectal Neoplasms; Stomach Neoplasms; Solid Tumor Malignancies | 78 |
| Elixiron Immunotherapeutics Inc. | Phase 1 | Food Effect in Healthy Volunteers | 25 |
| Pfizer | Phase 1 | Pancreatic Ductal Adenocarcinoma; Esophageal Cancer; Carcinoma, Non-Small-Cell Lung (NSCLC); Gastric Carcinoma; Gastroesophageal Junction Adenocarcinoma | 280 |
| North Immunology Inc. | Phase 1 | Atopic Dermatitis (AD) | 96 |
| BeOne Medicines | Phase 1 | Solid Tumors; Advanced Solid Tumors | 90 |
| Sinocelltech Ltd. | Phase 1 | Hepatitis B | 60 |
| Sanofi | Phase 1 | Healthy Volunteers | 40 |
| AnHorn Medicines Co. Ltd. | Phase 1 | Chemotherapy-induced Peripheral Neuropathy (CIPN) | 32 |
| Insmed Gene Therapy LLC | Phase 1 | Duchenne Muscular Dystrophy | 12 |
| Rigerna Therapeutics Co., Ltd.; Rigerna Therapeutics (Beijing) Co., Ltd. | Phase 1 | Safety Issues | 30 |
| AJU Pharm Co., Ltd. | Phase 1 | Peripheral Arterial Disease | 40 |
| Helixon Biotechnology (Suzhou) Co., Ltd | Phase 1 | Health Adults; Asthma | 40 |
| Odyssey Therapeutics, Inc. | Phase 1 | Health Volunteers | 8 |
| AJU Pharm Co., Ltd. | Phase 1 | Hypertension | 60 |
| Keymed Biosciences Co.Ltd | Phase 1 | Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis) | 48 |
| Cajal Therapeutics Inc. | Phase 1 | Chronic Kidney Disease; Anemia | 24 |
| Accro Bioscience (Suzhou) Limited | Phase 1 | Acute Graft-versus-Host Disease | 4 |
| Pfizer | Phase 1 | Alzheimer Disease | 98 |
| Pneumagen Ltd, a subsidiary of NorthLinks Bio | Phase 1 | Healthy Volunteers | 44 |
| Axter Therapeutics (Beijing) Co., Ltd | Phase 1 | mCRPC | 105 |
| Viatris Innovation GmbH | Phase 1 | Chronic Coronary Syndrome | 20 |
| Cerenome | Phase 1 | Leptomeningeal Metastasis | 37 |
| BeOne Medicines | Phase 1 | Solid Tumor; Advanced Solid Tumor; Metastatic Solid Tumor | 96 |
| Nuwacell Biotechnologies Co., Ltd. | Phase 1 | PARKINSON DISEASE (Disorder); Cell Therapy; Human Induced Pluripotent Stem Cells; Deep Brain Stimulation; Phase 1 Clinical Trial; Dopaminergic Progenitor Cells | 12 |
| Kyowa Kirin Co., Ltd. | Phase 1 | Advanced Solid Tumor; Metastatic Solid Tumor; Gastric Adenocarcinoma; Gastroesophageal Junction Adenocarcinoma; Esophageal Adenocarcinoma; Non Small Cell Lung Cancer | 83 |
| ADARx Pharmaceuticals, Inc. | Phase 1 | Hypertension; Hypertension,Essential | 28 |
| Novo Nordisk A/S | Phase 1 | Healthy Volunteers; Hyperuricemia | 50 |
| Bayer | Phase 1 | Healthy Participants | 42 |
| Ascletis Pharma (China) Co., Limited | Phase 1 | Chronic Weight Management | 144 |
| Biogen | Phase 1 | Healthy Volunteer; Muscular Atrophy, Spinal | 62 |
| Lantheus Germany GmbH | Phase 1 | Cardiac Amyloidosis | 15 |
| Genentech, Inc. | Phase 1 | Hepatic Impairment | 27 |
| BeOne Medicines | Phase 1 | Healthy Volunteers | 12 |
| iBio, Inc. | Phase 1 | Obesity & Overweight | 32 |
| Aktis Oncology, Inc. | Phase 1 | NSCLC; NSCLC (Advanced Non-small Cell Lung Cancer); ES-SCLC; Small Cell Lung Cancer Extensive Stage; B7H3; Prostate Cancer | 152 |
| Beijing Suncadia Pharmaceuticals Co., Ltd | Phase 1 | Alzheimer's Disease | 50 |
| Ono Pharmaceutical Co., Ltd. | Phase 1 | Colorectal Cancer | 40 |
| CureVac | Phase 1 | Squamous NSCLC | |
| University of Arizona | Phase 1 | Acute Lymphoid Leukemia; Acute Myeloid Leukemia; Acute Undifferentiated Leukemia (AUL); Myelodysplastic Syndrome; Chronic Myeloid Leukemia; Non-Hodgkin Lymphoma | 180 |
| Arsenal Biosciences, Inc. | Phase 1 | Carcinoma, Ovarian Epithelial; Ovarian Neoplasms; Fallopian Tube Neoplasms; Peritoneal Neoplasms; Neoplasms, Glandular and Epithelial; Ovarian Diseases | 19 |
| University of South Florida | Phase 1 | Migraine; Migraine Disease; Migraine in Adults; Migraine Headache; Acute Migraine; Migraine Without Aura | 100 |
| Outpace Bio, Inc. | Phase 1 | Ovarian Cancer Recurrent; Ovarian Cancer; Platinum Resistant Ovarian Cancer | 3 |
| Yuhan Corporation | Phase 1 | Healthy Subjects (HS) | 44 |
| Haisco Pharmaceutical Group Co., Ltd. | Phase 1 | Non-cystic Fibrosis Bronchiectasis (NCFBE) | 30 |
| Yuhan Corporation | Phase 1 | Healthy Subjects (HS) | 44 |
| Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd | Phase 1 | Hepatic Impairment | 25 |
| Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd | Phase 1 | Mass Balance Study | 6 |
| Cibus Therapeutics, Inc. | Phase 1 | Chronic Pancreatitis | 32 |
| Mabsoft Therapeutics (Shanghai) Co., Ltd. | Phase 1 | Ankylosing Spondylitis (AS) | 32 |
| Anhui HygeianCells BioMedical Co., Ltd. | Phase 1 | Knee Arthritis, Osteoarthritis | 26 |
| Jiangsu Hansoh Pharmaceutical Co., Ltd. | Phase 1 | Healthy Participants | 32 |
| Metaclipse Therapeutics Corporation | Phase 1 | Squamous Cell Carcinoma of Head and Neck; Squamous Cell Carcinoma of Head and Neck (SCCHN); HNSCC; Neoplasm Recurrence, Local; Recurrent Head and Neck Squamous Cell Carcinoma | 30 |
| Ascletis Pharma (China) Co., Limited | Phase 1 | Chronic Weight Management | 86 |
| GuangZhou Cellgenes Biotechnology Co., Ltd. | Phase 1 | Acute Respiratory Distress Syndrome (ARDS) | 15 |
| ViiV Healthcare | Phase 1 | HIV Infections | 112 |
| Innovent Biologics (Suzhou) Co. Ltd. | Phase 1 | Obesity and Overweight | 128 |
| AbbVie | Phase 1 | Advanced Solid Tumors; Non-Small Cell Lung Cancer; Colorectal Cancer; Pancreatic Ductal Adenocarcinoma; Gastric Cancer; Gastroesophageal Junction Adenocarcinoma | 130 |
| Adlai Nortye Biopharma Co., Ltd. | Phase 1 | Solid Tumor (Phase I); RAS Mutation; CEACAM5 | 228 |
| Shanghai EpimAb Biotherapeutics Co., Ltd. | Phase 1 | Unresectable/Metastatic Colorectal Cancer | 120 |
| Amgen | Phase 1 | Healthy Participants | 308 |
| Eli Lilly and Company | Phase 1 | Obesity; Overweight | 184 |
| Sunshine Lake Pharma Co., Ltd. | Phase 1 | Advanced Malignant Solid Tumors | 110 |
| Mayo Clinic | Phase 1 | Chronic Pancreatitis | 30 |
| M.D. Anderson Cancer Center | Phase 1 | Melanoma | 50 |
| National Cancer Institute (NCI) | Phase 1 | Malignancy, Hematologic; Neoplasms, Hematologic; Neoplasms, Hematopoietic; Blood Cancer; Hematological Neoplasms; Hematopoietic Malignancies | 86 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 1 | Liver Cancer (Fibrolamellar Hepatocellular Cancer (FLC)) | 27 |
| National Cancer Institute (NCI) | Phase 1 | Recurrent Small Cell Lung Cancer; Extensive-Stage Small Cell Lung Cancer; Small Cell Lung Cancer; Small Cell Lung Carcinoma; Refractory Small Cell Lung Cancer; Extrapulmonary Small Cell Carcinoma | 40 |
| Radboud University Medical Center | Phase 1 | Thyroid Cancer Stage IV; Anaplastic Thyroid Cancer; Differentiated Thyroid Cancer; Poorly Differentiated Thyroid Carcinoma | 10 |
| AIMEDBIO | Phase 1 | Solid Tumours | 86 |
| University of Chicago | Phase 1 | Lung Cancer | 30 |
| Juan Luis Vásquez | Phase 1 | Bladder Tumors; Bladder Tumor; Urothelial Carcinoma (UC); Urothelial Carcinoma Bladder | 20 |
| Stanford University | Phase 1 | Large-cell Lymphoma | 20 |
| University of Illinois Chicago | Phase 1 | Plasmablastic Lymphoma; HIV; Consolidation | 17 |
| Innovent Biologics (Suzhou) Co. Ltd. | Phase 1 | IgA Nephropathy (IgAN) | 100 |
| Ausper Biopharma Co., Ltd. | Phase 1 | Chronic Hepatitis B Virus | 110 |
| Eli Lilly and Company | Phase 1 | Obesity; Overweight; Diabetes Mellitus, Type 2 | 617 |
| Hoffmann-La Roche | Phase 1 | Locally Advanced or Metastatic Solid Tumors | 405 |
| Pfizer | Phase 1 | Overweight and/or Obesity | 150 |
| Pfizer | Phase 1 | Overweight and/or Obesity; Healthy Participants | 144 |
| Shanghai Qilu Pharmaceutical Research and Development Center LTD | Phase 1 | Advanced Prostate Cancer | 252 |
| AstraZeneca | Phase 1 | Healthy Participants | 100 |
| Genentech, Inc. | Phase 1 | Advanced or Metastatic Breast Cancer | 165 |
| Eli Lilly and Company | Phase 1 | Healthy; Type 1 Diabetes Mellitus | 121 |
| Corsera Health | Phase 1 | Otherwise Healthy Individuals With Systolic Blood Pressure (SBP) From 110 to 139 mmHg and Low-density Lipoprotein Cholesterol (LDL-C) ≥ 100 mg/dL | 108 |
| Genentech, Inc. | Phase 1 | Colorectal Neoplasms; Pancreatic Ductal Adenocarcinoma | 388 |
| SystImmune Inc. | Phase 1 | Locally Advanced /Metastatic Solid Tumors; Locally Advanced / Metastatic Solid Tumors; Metastatic Solid Cancers; Non Small Cell Lung Cancer; Lung Cancer; Melanoma | 424 |
| IDRX, Inc., a wholly owned subsidiary of GSK, LLC | Phase 1 | Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumor (GIST); Digestive System Disease; Gastrointestinal Diseases; Metastatic Cancer | 276 |
| Merck Sharp & Dohme LLC | Phase 1 | Lower Respiratory Tract Infection | 564 |
| Gan & Lee Pharmaceuticals. | Phase 1 | Hypoalbuminemia in Cirrhotic Ascites | 106 |
| Hangzhou DAC Biotechnology Co., Ltd. | Phase 1 | Advanced Solid Tumors | 110 |
| Juno Therapeutics, Inc., a Bristol-Myers Squibb Company | Phase 1 | Clear Cell Renal Cell Carcinoma (ccRCC) | 112 |
| Eli Lilly and Company | Phase 1 | Healthy Volunteers; Alzheimer Disease; Amyloid; Plaque, Amyloid; Plasma | 111 |
| ViiV Healthcare | Phase 1 | HIV Infections | 107 |
| Fujian Shengdi Pharmaceutical Co., Ltd. | Phase 1 | Weight Management; Type 2 Diabetes | 122 |
| Janssen Research & Development, LLC | Phase 1 | Leukemia, Myeloid, Acute | 196 |
| AstraZeneca | Phase 1 | B-cell Non Hodgkin Lymphoma; Diffuse Large B Cell Lymphoma; High-grade B-cell Lymphoma; Follicular Lymphoma | 226 |
| Jiangsu Aosaikang Pharmaceutical Co., Ltd. | Phase 1 | Solid Tumor; RAS Mutation | 200 |
| Hansoh BioMedical R&D Company | Phase 1 | Solid Tumors | 595 |
| Hoffmann-La Roche | Phase 1 | Healthy Volunteers | 105 |
| Amgen | Phase 1 | Overweight; Obesity | 340 |
| Qilu Pharmaceutical Co., Ltd. | Phase 1 | RAS Wild-type Metastatic Colorectal Cancer | 136 |
| Ponce Medical School Foundation, Inc. | Phase 1 | CASA Intervention; Usual Care | 114 |
| ViiV Healthcare | Phase 1 | HIV Infections | 160 |
| Pfizer | Phase 1 | Multiple Myeloma | 100 |
| Stanford University | Phase 1 | PARKINSON DISEASE (Disorder) | 50 |
| Ain Shams University | Phase 1 | Intra and Post Operative Pain Management; Fast Track Program,(Enhanced Recovery After Surgery (ERAS)) | 111 |
| City of Hope Medical Center | Phase 1 | B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | 21 |
| M.D. Anderson Cancer Center | Phase 1 | Colorectal Cancer; Minimal Residual Disease | 10 |
| M.D. Anderson Cancer Center | Phase 1 | Malignant Neoplasm of Breast; Malignant Neoplasms of Digestive Organs; Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System; Malignant Neoplasms of Female Genital Organs; Malignant Neoplasms of Ill-defined Secondary and Unspecified Sites; Malignant Neoplasms of Independent (Primary) Multiple Sites | 18 |
| Zhejiang University | Phase 1 | Mesothelin-Positive Advanced Solid Tumors With Peritoneal Metastasis | 10 |
| Unity Health Toronto | Phase 1 | GBM | 6 |
| University of Wisconsin, Madison | Phase 1 | High-risk Myeloid Malignancy; Allogenic Stem Cell Transplantation; Acute Myeloid Leukemia (AML); Chronic Myeloid Leukemia (CML); Primary Myelofibrosis (PMF); Intermediate-risk Myelodysplastic Syndrome | 27 |
| Assistance Publique Hopitaux De Marseille | Phase 1 | Meningioma | 32 |
| Weill Medical College of Cornell University | Phase 1 | Anal Fistula | 39 |
| National Cancer Institute (NCI) | Phase 1 | Kaposi Sarcoma | 62 |
| McGill University Health Centre/Research Institute of the McGill University Health Centre | Phase 1 | Tuberculosis Infection; Healthy Volunteer; Breastfeeding | 60 |
| University of Michigan | Phase 1 | Appendicitis (Diagnosis) | 53 |
| National Heart, Lung, and Blood Institute (NHLBI) | Phase 1 | Pulmonary Arterial Hypertension PAH | 40 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 | COVID-19 | 60 |
| Seattle Children's Hospital | Phase 1 | Acute Myeloid Leukemia; Acute Myeloid Leukaemia Recurrent; Acute Myeloid Leukaemia Refractory | 20 |
| Women's Hospital School Of Medicine Zhejiang University | Phase 1 | Primary Ovarian Insufficiency | 12 |
| Duke University | Phase 1 | Coronavirus Infection | 36 |
| City of Hope Medical Center | Phase 1 | Chronic Lymphocytic Leukemia; Diffuse Large B-Cell Lymphoma; Follicular Lymphoma; Indolent Non-Hodgkin Lymphoma; Lymphoplasmacytic Lymphoma; Marginal Zone Lymphoma | 27 |
| Memorial Sloan Kettering Cancer Center | Phase 1 | Malignant Pleural Mesothelioma (MPM) | 14 |
| M.D. Anderson Cancer Center | Phase 1 | Non Small Cell Lung Cancer | 24 |
| University of Pennsylvania | Phase 1 | Chemotherapy Resistant Acute Lymphoblastic Leukemia; Refractory Acute Lymphoblastic Leukemia | 23 |
| American College of Radiology | Phase 1 | Head and Neck Cancer; Head and Neck Squamous Cell Carcinoma; Squamous Cell Carcinoma of the Larynx; Squamous Cell Carcinoma of the Oropharynx; Squamous Cell Carcinoma of the Oral Cavity | 14 |
| Dana-Farber Cancer Institute | Phase 1 | Pancreatic Ductal Adenocarcinoma; Pancreatic Cancer; Resectable Pancreatic Ductal Adenocarcinoma | 30 |
| London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Phase 1 | Depression - Major Depressive Disorder; Generalized Anxiety Disorder (GAD); Anxiety | 62 |
| Universität Münster | Phase 1 | Neuroblastoma (NBL); Ewing Sarcoma; Osteosarcoma | 30 |
All ClinicalTrialStartPulse record reports